RESUMO
São Paulo is a state in Brazil with one of the highest numbers of confirmed and severe cases of coronavirus disease (COVID-19), with an incidence of 294 hospitalizations per 100,000 inhabitants. We report the clinical characteristics and outcomes of 120,804 hospitalized patients with confirmed COVID-19 from February 26 to October 10, 2020, in São Paulo. Characteristics of patients who died and survived were compared using a survival analysis. The median age was 60 years (interquartile range [IQR], 47-72), 67,821 (56.1%) were men, and 61,659 (51.0%) were white. Most hospitalized patients (79,812; 66.1%) reported one or more comorbidities, 41,708 (34.5%) hospitalized patients were admitted to intensive care units, and 33,079 (27.4%) died. Men (hazard ratio [HR], 1.22; 95% confidence interval [CI], 1.18-1.25), elderly individuals (HR, 3.85; 95% CI, 3.68-4.02), and patients with chronic cardiovascular disease including hypertension (HR, 1.05; 95% CI, 1.02-1.08), chronic lung disease (HR, 1.38; 95% CI, 1.31-1.45), diabetes mellitus (HR, 1.14; 95% CI, 1.11-1.18), and chronic neurological disease (HR, 1.48; 95% CI, 1.41-1.55) were at higher risk for death from COVID-19.
Assuntos
COVID-19/epidemiologia , COVID-19/mortalidade , SARS-CoV-2 , Adulto , Idoso , Brasil/epidemiologia , COVID-19/complicações , Doenças Cardiovasculares/complicações , Doenças do Sistema Nervoso Central/complicações , Diabetes Mellitus , Feminino , Humanos , Pacientes Internados , Pneumopatias/complicações , Masculino , Pessoa de Meia-Idade , Fatores de RiscoRESUMO
INTRODUCTION: The state of São Paulo has been monitoring cases of microcephaly and pregnant women presenting with acute rash, through CeVeSP. METHODS: This was a descriptive study focusing on pregnant women with rash and the outcome of their pregnancy, based on the notifications through the CeVeSP. RESULTS: During 2016, 2,209 cases of pregnant women with rash were reported and investigated. Of these, 36.6% were confirmed. Of the pregnant women who tested positive for ZIKV, 6.4% did not have a favorable outcome. CONCLUSIONS: Our results allowed the characterization of pregnant women exposed to ZIKV and the outcome of pregnancy.
Assuntos
Exantema/diagnóstico , Complicações Infecciosas na Gravidez/diagnóstico , Vigilância de Evento Sentinela , Infecção por Zika virus/diagnóstico , Adolescente , Adulto , Brasil/epidemiologia , Exantema/epidemiologia , Exantema/virologia , Feminino , Humanos , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Adulto Jovem , Infecção por Zika virus/epidemiologiaRESUMO
Abstract INTRODUCTION: The state of São Paulo has been monitoring cases of microcephaly and pregnant women presenting with acute rash, through CeVeSP. METHODS: This was a descriptive study focusing on pregnant women with rash and the outcome of their pregnancy, based on the notifications through the CeVeSP. RESULTS: During 2016, 2,209 cases of pregnant women with rash were reported and investigated. Of these, 36.6% were confirmed. Of the pregnant women who tested positive for ZIKV, 6.4% did not have a favorable outcome. CONCLUSIONS Our results allowed the characterization of pregnant women exposed to ZIKV and the outcome of pregnancy.
Assuntos
Humanos , Feminino , Gravidez , Adolescente , Adulto , Adulto Jovem , Complicações Infecciosas na Gravidez/diagnóstico , Vigilância de Evento Sentinela , Exantema/diagnóstico , Infecção por Zika virus/diagnóstico , Complicações Infecciosas na Gravidez/epidemiologia , Brasil/epidemiologia , Exantema/epidemiologia , Exantema/virologia , Infecção por Zika virus/epidemiologiaRESUMO
INTRODUCTION: The state of São Paulo has been monitoring cases of microcephaly and pregnant women presenting with acute rash, through CeVeSP. METHODS: This was a descriptive study focusing on pregnant women with rash and the outcome of their pregnancy, based on the notifications through the CeVeSP. RESULTS: During 2016, 2,209 cases of pregnant women with rash were reported and investigated. Of these, 36.6% were confirmed. Of the pregnant women who tested positive for ZIKV, 6.4% did not have a favorable outcome. CONCLUSIONS Our results allowed the characterization of pregnant women exposed to ZIKV and the outcome of pregnancy.
Assuntos
Organização Mundial da Saúde , Monitoramento Ambiental , Estado , Gestantes , Zika virusRESUMO
OBJETIVO: descrever a taxa de detecção de infecção pelo vírus da hepatite B no Brasil e a razão de taxas de detecção nos municípios segundo cobertura dos serviços de hemoterapia (SH) durante o período 2001-2008. MÉTODOS: estudo descritivo, compreendeu o cálculo da taxa de detecção de infecção pelo vírus da hepatite B por sexo, faixa etária, Regiões brasileiras e presença de SH; regressão linear para tendência; teste de qui-quadrado para comparação de proporções da detecção e razão de taxas; os dados foram coletados do Sistema de Informação de Agravos de Notificação (Sinan-NET). RESULTADOS: a taxa de detecção de infecção pelo vírus da hepatite B apresentou incremento no Brasil, sendo 2,4 vezes mais elevada nos municípios com SH. CONCLUSÃO: a detecção da infecção pelo vírus da hepatite B apresentou pequeno incremento no período estudado e em todas as Regiões brasileiras foram encontradas taxas mais elevadas em municípios com serviço de hemoterapia.
OBJECTIVE: to describe the detection rate of infection by hepatitis B virus in Brazil and detection rates ratio in municipalities regarding hemotherapy service (HS) during the period 2001-2008. METHODS: a descriptive study reached the detection rate of infection by hepatitis Bvirus by gender, age, Brazilian macro-regions and presence of HS; it was applied linear regression for trend, and chi-squared test to compare proportions of detection and ratio rates; data from the Reportable Diseases Database (Sinan-NET) was used. RESULTS: the detection rates of infection by hepatitis B virus showed increase in Brazil, and were 2.4 higherin municipalities with HS. CONCLUSION: the detection of infection by hepatitis B virus showed small increase during the study period, and all Brazilian regions presented higher rates in municipalities with hemotherapy service.